Hinge Health HNGE
NYSE HNGE
$92.45 +1.63 (+1.79%)
At close: Sep 4, 2026 · 4:00 PM EDT

Hinge Health (HNGE) Price to Sales (2025 - 2026)

Hinge Health's (HNGE) quarterly Price to Sales came in at 31.28 in Q2 2026, up 4.17% year-over-year from 30.03 in Q2 2025, and up 91.3% quarter-over-quarter from 16.35 in Q1 2026.

Analysis

Hinge Health (HNGE) Price to Sales (2025 - 2026) Analysis & Trends

Hinge Health has disclosed Price to Sales across 2 years of filings, most recently posting 31.28 for Q2 2026.

  • In Q2 2026, Price to Sales rose 4.17% year-over-year to 31.28; the TTM figure through Jun 2026 stood at 9.24 (up 6.42% YoY), while the FY2025 annual figure was 6.26, changed N/A from the prior year.
  • Price to Sales came in at 31.28 for Q2 2026 at Hinge Health, up from 16.35 in the prior quarter.
  • In the past five years, Price to Sales ranged from a high of 31.28 in Q2 2026 to a low of 16.35 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn
7 Akso Health 259.44 Mn 259.25 Mn -
8 LifeMD 147.29 Mn 147.29 Mn -
9 eHealth 31.71 Mn -69.34 Mn -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.28
Mar 31, 2026 16.35
Dec 31, 2025 21.54
Sep 30, 2025 25.05
Jun 30, 2025 30.03